Iambic Therapeutics Unveils Enchant AI to Predict Clinical Outcomes Using Preclinical Data
Iambic Therapeutics has announced the launch of Enchant, an AI platform designed to predict clinical outcomes from the earliest stages …
All Posts
Stem Cell Transplant 'Black Box' Unveiled in 31-Year Study of Blood Cells
A pioneering study has provided the first detailed insight into the long-term behavior of stem cells following transplants, offering new …
Global Pharma R&D Investments Surpass $276 Billion Annually, Exceeding Previous Estimates
A recent study, titled Comprehensive Measurement of Biopharmaceutical R&D Investment, published in Nature Reviews Drug Discovery, reveals that global pharmaceutical …
Benchling Acquires PipeBio to Enhance AI-Powered Antibody Discovery
Benchling, a cloud-based R&D software provider, has acquired PipeBio, a bioinformatics company specializing in high-throughput sequence analysis for biologics discovery. …
Laverock Therapeutics to Showcase New Data on Expanding Gene-Silencing Platform at ESGCT 2024
Following recent advancements in its gene-silencing technology, UK-based Laverock Therapeutics is set to present new data at the European Society …
Life Biosciences Presents New Data on Epigenetic Reprogramming for Optic Neuropathies at AAO 2024
Life Biosciences, a biotech company advancing therapies to reverse aging-related diseases, shared new findings at the American Academy of Ophthalmology …
Beyond Traditional Clinical Trials: MEDSIR’s Adaptive Designs and Precision Medicine in Oncology
MEDSIR (Medica Scientia Innovation Research) is an international company, based in Barcelona and New Jersey, specializing in the design and …
Recursion Begins Phase 2 Trial for AI-Developed Non-Antibiotic Treatment for Recurrent C. diff. Infection
Recursion, an AI-driven drug discovery company, has dosed the first patient in its Phase 2 ALDER trial for REC-3964, an …
Combatting Antibiotic Resistance: Global Superbug Map Supports Phage Therapy Development
A new global "superbug map" has been developed to track the spread of Acinetobacter baumannii, a critically antibiotic-resistant species often …
Univercells Technologies Introduces the Scale-X Nexo Bioreactor for Enhanced Cell Culture Process Development
Univercells Technologies by Donaldson has launched the scale-X nexo bioreactor, a new addition to its scale-X portfolio, designed to support …
British Patient Capital Invests £8M in Nuclera as Part of $75M Series C Funding
British Patient Capital has announced an £8 million investment in biotechnology company Nuclera, contributing to a $75 million Series C …
First Human Skin Map Could Aid in Regenerative Medicine and Scar Prevention
Researchers from the Wellcome Sanger Institute, Newcastle University, and their collaborators have created a detailed single-cell atlas of prenatal human …